BETHESDA, Md. - The director for the National Institutes of Health announced this week the progress of a nasal spray being developed to treat COVID-19. "I’m pleased to share progress in the development of a specially engineered therapeutic antibody that could be delivered through a nasal spray.
Preclinical studies also suggest it may work even better than existing antibody treatments to fight COVID-19, especially now that new SARS-CoV-2 "variants of concern" have become increasingly prevalent," said NIH director Dr.